These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26740346)

  • 21. The community-based prevention of diabetes (ComPoD) study: a randomised, waiting list controlled trial of a voluntary sector-led diabetes prevention programme.
    Smith JR; Greaves CJ; Thompson JL; Taylor RS; Jones M; Armstrong R; Moorlock S; Griffin A; Solomon-Moore E; Biddle MSY; Price L; Abraham C
    Int J Behav Nutr Phys Act; 2019 Nov; 16(1):112. PubMed ID: 31771589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Efficacy of an Electronic, Culturally Adapted Lifestyle Counseling Tool for Improving Diabetes-Related Dietary Knowledge: Randomized Controlled Trial Among Ethnic Minority Adults With Type 2 Diabetes Mellitus.
    Abu-Saad K; Murad H; Barid R; Olmer L; Ziv A; Younis-Zeidan N; Kaufman-Shriqui V; Gillon-Keren M; Rigler S; Berchenko Y; Kalter-Leibovici O
    J Med Internet Res; 2019 Oct; 21(10):e13674. PubMed ID: 31621640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of a Yoga-Based Lifestyle Protocol (YLP) in Preventing Diabetes in a High-Risk Indian Cohort: A Multicenter Cluster-Randomized Controlled Trial (NMB-Trial).
    Raghuram N; Ram V; Majumdar V; Sk R; Singh A; Patil S; Anand A; Judu I; Bhaskara S; Basa JR; Nagendra HR
    Front Endocrinol (Lausanne); 2021; 12():664657. PubMed ID: 34177805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lifestyle intervention for people with diabetes or prediabetes in real-world primary care: propensity score analysis.
    Linmans JJ; Spigt MG; Deneer L; Lucas AE; de Bakker M; Gidding LG; Linssen R; Knottnerus JA
    BMC Fam Pract; 2011 Sep; 12():95. PubMed ID: 21914190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial.
    Alzeidan R; Shata Z; Hassounah MM; Baghdadi LR; Hersi A; Fayed A; Kashour T; Elmorshedy H
    BMC Public Health; 2019 Nov; 19(1):1550. PubMed ID: 31752774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective translation of a type-2 diabetes primary prevention programme into routine primary care: The PreDE cluster randomised clinical trial.
    Sanchez A; Silvestre C; Campo N; Grandes G;
    Diabetes Res Clin Pract; 2018 May; 139():32-42. PubMed ID: 29476888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digitally supported program for type 2 diabetes risk identification and risk reduction in real-world setting: protocol for the StopDia model and randomized controlled trial.
    Pihlajamäki J; Männikkö R; Tilles-Tirkkonen T; Karhunen L; Kolehmainen M; Schwab U; Lintu N; Paananen J; Järvenpää R; Harjumaa M; Martikainen J; Kohl J; Poutanen K; Ermes M; Absetz P; Lindström J; Lakka TA;
    BMC Public Health; 2019 Mar; 19(1):255. PubMed ID: 30823909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engaging primary care professionals in collaborative processes for optimising type 2 diabetes prevention practice: the PREDIAPS cluster randomised type II hybrid implementation trial.
    Sanchez A; Grandes G; Pablo S; Espinosa M; Torres A; García-Alvarez A;
    Implement Sci; 2018 Jul; 13(1):94. PubMed ID: 29996928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment.
    Sakane N; Kotani K; Takahashi K; Sano Y; Tsuzaki K; Okazaki K; Sato J; Suzuki S; Morita S; Izumi K; Kato M; Ishizuka N; Noda M; Kuzuya H
    BMC Public Health; 2013 Jan; 13():81. PubMed ID: 23356246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
    Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.
    Gillett M; Royle P; Snaith A; Scotland G; Poobalan A; Imamura M; Black C; Boroujerdi M; Jick S; Wyness L; McNamee P; Brennan A; Waugh N
    Health Technol Assess; 2012 Aug; 16(33):1-236, iii-iv. PubMed ID: 22935084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of the DP-TRANSFERS project in Catalonia: A translational method to improve diabetes screening and prevention in primary care.
    Costa-Pinel B; Mestre-Miravet S; Barrio-Torrell F; Cabré-Vila JJ; Cos-Claramunt X; Aguilar-Sanz S; Solé-Brichs C; Castell-Abat C; Arija-Val V; Lindström J;
    PLoS One; 2018; 13(3):e0194005. PubMed ID: 29543842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP).
    Mathews E; Thomas E; Absetz P; D'Esposito F; Aziz Z; Balachandran S; Daivadanam M; Thankappan KR; Oldenburg B
    BMC Public Health; 2018 Jan; 17(1):974. PubMed ID: 29298703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Walking Away from Type 2 diabetes: a cluster randomized controlled trial.
    Yates T; Edwardson CL; Henson J; Gray LJ; Ashra NB; Troughton J; Khunti K; Davies MJ
    Diabet Med; 2017 May; 34(5):698-707. PubMed ID: 27589017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding type 2 diabetes mellitus screening practices among primary care physicians: a qualitative chart-stimulated recall study.
    Hafez D; Nelson DB; Martin EG; Cohen AJ; Northway R; Kullgren JT
    BMC Fam Pract; 2017 Apr; 18(1):50. PubMed ID: 28376802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes risk reduction in overweight first degree relatives of type 2 diabetes patients: effects of a low-intensive lifestyle education program (DiAlert) A randomized controlled trial.
    Heideman WH; de Wit M; Middelkoop BJ; Nierkens V; Stronks K; Verhoeff AP; Snoek FJ
    Patient Educ Couns; 2015 Apr; 98(4):476-83. PubMed ID: 25577471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yoga programme for type-2 diabetes prevention (YOGA-DP) among high risk people in India: a multicentre feasibility randomised controlled trial protocol.
    Chattopadhyay K; Mishra P; Singh K; Harris T; Hamer M; Greenfield SM; Lewis SA; Manjunath NK; Nair R; Mukherjee S; Harper DR; Tandon N; Kinra S; Prabhakaran D;
    BMJ Open; 2020 Sep; 10(9):e036277. PubMed ID: 32895271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Process evaluation of a randomised controlled trial of a diabetes prevention intervention in Dutch primary health care: the SLIMMER study.
    van Dongen EJ; Duijzer G; Jansen SC; Ter Beek J; Huijg JM; Leerlooijer JN; Hiddink GJ; Feskens EJ; Haveman-Nies A
    Public Health Nutr; 2016 Nov; 19(16):3027-3038. PubMed ID: 27256153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program.
    Vojta D; Koehler TB; Longjohn M; Lever JA; Caputo NF
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S301-6. PubMed ID: 23498291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.